Categories:
Do you know that Vita conducts systematic reviews in accordance with ANVISA Guide 61?
For synthetic and semisynthetic drug products, Resolutions RDC No. 753/2022 and RDC No. [...]
Ler mais
ANVISA Holds Reliance Workshop in Brasília
On September 18, ANVISA held, in Brasília, the Reliance Workshop. The event was held in a [...]
Ler mais
RDC 997/2025: Understanding the Resolution’s Impact and Developments in ANVISA’s Application Review
In November 2025, ANVISA published Resolution RDC No. 997, of November 7, 2025, which governs [...]
Ler mais
ANVISA approves pilot project for optimized quality review based on the REQ
On September 9, 2026, ANVISA published Normative Instruction (IN) No. 469/2026, which [...]
Ler mais
Vita Participates: ANVISA Seminar on the New Regulatory Framework for Herbal Medicines
On August 28, Vita attended the seminar hosted by ANVISA in Brasília on the new regulatory [...]
Ler mais
ANVISA publishes IN 467/2026: List of qualified impurities and their respective limits in accordance with RDC No. 964, from February 20, 2025.
On August 26, 2026, ANVISA published Normative Instruction (IN) No. 467/2026, amending IN No. [...]
Ler mais
ANVISA updates Q&A on relative bioavailability/bioequivalence studies (Resolution RDC No. 742/2022) – updated on 10/28/2026
Since August 2026, ANVISA has published three updates to its Questions and Answers document on [...]
Ler mais
ANVISA opens to contributions for the review of the regulatory framework for biological products
On August 20, 2026, Brazil’s Health Regulatory Agency (ANVISA) opened a technical [...]
Ler mais
ANVISA releases priority queues for GMP certification applications
Brazil’s Health Regulatory Agency (ANVISA) has begun publishing queues of Good [...]
Ler mais
ANVISA – new application form for GMP certification for advanced therapy medicinal products
On August 14, 2026, Brazil’s Health Regulatory Agency (ANVISA) released the new Good [...]
Ler mais
ANVISA updates guidance on Periodic Benefit-Risk Evaluation Reports (PBRER)
A new schedule for preparing Periodic Benefit-Risk Evaluation Reports (PBRER) took effect on [...]
Ler mais
Health surveillance: the network that follows every stage of Brazilians’ day
Established under Law No. 13,098/2015, Brazil’s National Health Surveillance Day is [...]
Ler mais